16th October 2014
The Adis Custom Intelligence Service consists of a flexible portfolio of solutions designed to answer some of the key questions facing the pharmaceutical industry and offers a variety of reports to provide more in-depth analysis in this area. In addition to serving the pharmaceutical industry, Adis Custom Intelligence helps non-pharmaceutical organisations who need to draw on specific industry research on a periodic basis, such as the financial and legal markets who may use it for due diligence and M&A purposes. Adis was bought by Springer in 2011. Sophie Alexander recently interviewed William Stow and Donald Schumacher to find out more about the product.
Access to Jinfo articles and reports is a benefit of a Jinfo Subscription.
Please sign in here so that we can check your access to this item:
If this item has been shared with you by a colleague, please request a MyJinfo account.
Gain access to this article with a Jinfo Subscription. It will help your organisation:
Benefits and Pricing
Submit the Subscription Question form to find out if someone in your organisation already has a subscription or to discuss your questions or requirements.Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
Claire LaybatsHead of Commercial Developmentclaire.firstname.lastname@example.org
Related Subscription Articles:
Related Blog items:
Back to top ^
« All Articles
Login to MyJinfo if you already have a Jinfo Subscription
Document the value chain, and transform the way you think about, manage and report on your product portfolio and your information service contributions to your organisation goals.
Focus on Value Chain
Risk assessment is a required process for a healthy information department. It gauges the ability of your services, team, portfolio and overall value to withstand stress.
Focus on Risk Assessment
Sorry, there seems to be a problem with Webinar and Community listings. Please let us know, by email to email@example.com. Thank you.